Good MorningEquities hovered near break even on Thursday following another decline in the Index of Leading Indicators. The index fell-0.4% in the Month of July making it the 4th straight month of decline but there is some good news. The -0.4% is a better read than the -0.5% indicated by the consensus estimate and an improvement from the prior months -0.7%. If this turns into a trend economic expansion could be back on the table by the end of the quarter but it is too soon to tell.
Next week could be a tough one for the market. There are very few earnings reports on the schedule but at least one major economic report that could move the market. The PCE price index is due out on Friday and will give the latest read on consumer inflation. A better-than-expected report will send the market higher. Featured: Trump’s treachery (Ad) 
|
Markets | | | Labor unions are pressuring U.S. airlines not to buy back their own stock but instead spend the money on hiring more workers and fixing problems that caused widespread flight delays and cancellations this summer.
The unions said Thursday that the four largest U.S. airlines spent more ... Read the Full Story |
|
From Our PartnersJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." | | | Click here to watch the demo… |
|
Stocks | | | Pharmaceutical stocks are frequently subject to whiplash trade, and that’s evident now with sharp moves lower in names such as Sanofi (NASDAQ: SNY), GSK (NYSE: GSK), and Teva Pharmaceuticals (NYSE: TEVA).
Price swings in that industry are often determined by the results of clinical tria... Read the Full Story |
|
Tech | | | The U.S. government will hold trade talks with Taiwan in a sign of support for the island democracy that China claims as its own territory, prompting Beijing to warn Thursday it will take action if necessary to “safeguard its sovereignty.”
The announcement of trade talks comes after B... Read the Full Story |
|
|
Markets | | |
I have a background in marketing. So it’s impossible for me to ignore the loyalty that Starbucks (NASDAQ:SBUX) receives from its customers. It shows up in my social media feed for sure. But I also notice that, even in the small-ish area I live in, Starbucks continues to expand, or at least r... Read the Full Story |
|
Politics | | | Global stock markets and Wall Street futures fell Friday after unexpectedly good U.S. jobs data left room for more interest rate hikes to cool inflation.
London, Shanghai, Tokyo and Frankfurt declined. Oil prices edged lower but stayed above $90 per barrel.
Fewer Americ... Read the Full Story |
|
|
Markets | | |
When it comes to the tech world there’s established, blue-chip tech and then there’s experimental tech and Cisco Systems (NASDAQ: CSCO) is as established as a company can be. The company manufactures, markets, and services IP-based networking, routing, and infrastructure components use... Read the Full Story |
|
Tech | | | The U.S. oil industry hit a legal roadblock in January when a judge struck down a $192 million oil and natural gas lease sale in the Gulf of Mexico over future global warming emissions from burning the fuels. It came at a pivotal time for Chevron, Exxon and other industry players: the Biden administ... Read the Full Story |
|
Markets | | |
BJ’s (NYSE: BJ) Wholesale Club Q2 results echo the strength seen in Sam’s Club segment at Walmart (NYSE: WMT). The two membership clubs posted record results driven by rising member counts that are underpinning a robust outlook for the year. Assuming these trends are true across the di... Read the Full Story |
|
Politics | | | A top executive at former President Donald Trump’s family business pleaded guilty Thursday to evading taxes in a deal with prosecutors that could potentially make him a star witness against the company at a trial this fall.
Trump Organization CFO Allen Weisselberg pleaded guilty to al... Read the Full Story |
|
Markets | | | If you’ve ever gotten a speed, red light, or school bus camera ticket in the mail, then you know how miserable they can be. At some point, you think to yourself that there’s got to be someone on the other side making a ton of money off these tickets. Well, there is a company making a ton... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom. The company's lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis; and anti-infectives portfolio includes SMT-738, a novel class of precision antibiotics for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. and its affiliates to develop and commercialize ivonescimab, as well as strategic collaboration with The University of Texas MD Anderson Cancer Center for the purpose of accelerating the development of ivonescimab. The company was founded in 2003 and is headquartered in Miami, Florida. | | View Today's Stock Pick |
|
